secwatch.observer — SEC 8-K summary
======================================

Issuer:     NewAmsterdam Pharma Co N.V. (NAMS)
CIK:        0001936258
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001193125-24-056922
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NewAmsterdam Pharma posts updated investor presentation; no material new data
-----------------------------------------------------------------------------

- Company posted updated corporate investor presentation on its website on March 4, 2024.
- Presentation contains no new financial results, guidance, or material operational updates.
- No earnings, M&A, or clinical data disclosed in the filing or exhibit.
- Routine update typical for investor relations purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/0001193125-24-056922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/d759933d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-056922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer